C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy

Despite the implementation of consolidative immune checkpoint inhibition after definitive chemoradiotherapy (CRT), the prognosis for locally advanced non-small-cell lung cancer (NSCLC) remains poor. We assessed the impact of the C-reactive protein (CRP) to albumin ratio (CAR) as an inflammation-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Frey, Alina, Martin, Daniel, D’Cruz, Louisa, Fokas, Emmanouil, Rödel, Claus, Fleischmann, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945805/
https://www.ncbi.nlm.nih.gov/pubmed/35327399
http://dx.doi.org/10.3390/biomedicines10030598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945805/
https://www.ncbi.nlm.nih.gov/pubmed/35327399
http://dx.doi.org/10.3390/biomedicines10030598

Ejemplares similares